NASDAQ : KROS
Keros Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 11.36 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 225.24M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Keros Therapeutics, Inc. (KROS) reported revenue of 15.01M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 15.01M | 244.06M | 3.55M | 151.00K | 20.10M | |
| Cost of Revenue | 73.36M | 127.14M | 173.63M | 135.26M | 87.27M | 55.14M |
| Gross Profit | -58.34M | 116.92M | -170.08M | -135.11M | -87.27M | -35.04M |
| Selling, General & Admin | 40.12M | 46.35M | 40.75M | 34.83M | 27.52M | 21.33M |
| Operating Expenses | 40.12M | 46.35M | 40.75M | 34.83M | 27.52M | 21.33M |
| Operating Income | -98.47M | 70.57M | -210.83M | -169.94M | -114.79M | -56.37M |
| Interest Expense | -1.00K | -4.00K | ||||
| Interest & Investment Income | 15.58M | 24.87M | 23.50M | 14.76M | 3.64M | 27.00K |
| Currency Exchange Gain (Loss) | -206.00K | -613.00K | ||||
| Other Non Operating Income (Expenses) | -206.00K | -539.00K | 284.00K | 2.40M | 7.08M | -383.00K |
| EBT Excluding Unusual Items | -83.10M | 94.90M | -187.05M | -152.99M | -104.68M | -56.73M |
| Merger & Restructuring Charges | -3.00M | -3.00M | ||||
| Pretax Income | -86.10M | 91.90M | -187.05M | -152.99M | -104.68M | -56.73M |
| Income Tax Expense | -2.94M | 4.88M | 300.00K | 2.01M | ||
| Net Income | -83.16M | 87.01M | -187.35M | -152.99M | -104.68M | -58.74M |
| Net Income to Common | -83.16M | 87.01M | -187.35M | -152.99M | -104.68M | -58.74M |
| Shares Outstanding (Basic) | 26.79M | 37.22M | 37.44M | 29.45M | 25.24M | 23.33M |
| Shares Outstanding (Diluted) | 26.79M | 37.86M | 37.44M | 29.45M | 25.24M | 23.33M |
| EPS (Basic) | -3.10 | 2.34 | -5.00 | -5.20 | -4.15 | -2.52 |
| EPS (Diluted) | -3.10 | 2.30 | -5.00 | -5.20 | -4.15 | -2.52 |
| Free Cash Flow | -48.49M | 105.95M | -162.80M | -126.97M | -71.30M | -63.17M |
| Free Cash Flow Per Share | -1.81 | 2.80 | -4.35 | -4.31 | -2.83 | -2.71 |
| Gross Margin | 47.91% | -174.34% | ||||
| Operating Margin | -655.84% | 28.91% | -5,938.96% | -112,543.71% | -280.46% | |
| Profit Margin | -553.88% | 35.65% | -5,277.55% | -101,319.21% | -292.26% | |
| Free Cash Flow Margin | -322.94% | 43.41% | -4,585.91% | -84,087.42% | -314.29% | |
| EBITDA | -96.87M | 72.08M | -209.60M | -169.13M | -114.12M | -55.99M |
| EBITDA Margin | 29.53% | -278.58% | ||||
| D&A For EBITDA | 1.60M | 1.51M | 1.23M | 815.00K | 674.00K | 378.00K |
| EBIT | -98.47M | 70.57M | -210.83M | -169.94M | -114.79M | -56.37M |
| EBIT Margin | 28.91% | -280.46% | ||||
| Effective Tax Rate | 5.31% | |||||
| Revenue as Reported | 15.01M | 244.06M | 3.55M | 151.00K | 20.10M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 257.61M | 287.42M | 559.93M | 331.15M | 279.05M | 230.04M |
| Cash & Short-Term Investments | 257.61M | 287.42M | 559.93M | 331.15M | 279.05M | 230.04M |
| Accounts Receivable | 3.57M | 2.74M | 143.00K | 18.00M | ||
| Other Receivables | 3.30M | 17.29M | 1.71M | 948.00K | 841.00K | 197.00K |
| Receivables | 3.30M | 20.85M | 4.46M | 1.09M | 841.00K | 18.20M |
| Prepaid Expenses | 2.31M | 2.76M | 1.76M | 1.64M | 2.28M | 1.38M |
| Other Current Assets | 3.66M | 4.40M | 22.74M | 13.42M | 3.60M | 1.82M |
| Total Current Assets | 266.88M | 315.43M | 588.89M | 347.29M | 285.77M | 251.44M |
| Property, Plant & Equipment | 19.27M | 21.14M | 23.49M | 19.47M | 17.57M | 2.40M |
| Other Long-Term Assets | 1.45M | 1.45M | 3.50M | 3.26M | 3.44M | 1.41M |
| Total Assets | 287.60M | 338.02M | 615.89M | 370.02M | 306.78M | 255.25M |
| Accounts Payable | 1.82M | 1.97M | 4.60M | 5.45M | 3.34M | 3.65M |
| Accrued Expenses | 7.20M | 12.45M | 20.45M | 17.25M | 12.00M | 7.03M |
| Current Portion of Leases | 2.60M | 2.41M | 1.98M | 1.00M | 455.00K | 862.00K |
| Current Income Taxes Payable | 55.00K | 3.38M | 110.00K | |||
| Other Current Liabilities | 482.00K | 217.00K | 416.00K | 665.00K | 750.00K | 204.00K |
| Total Current Liabilities | 12.15M | 20.41M | 27.45M | 24.37M | 16.55M | 11.85M |
| Long-Term Leases | 13.13M | 14.47M | 16.88M | 13.44M | 12.81M | 231.00K |
| Total Liabilities | 25.28M | 34.89M | 44.33M | 37.81M | 29.36M | 12.08M |
| Common Stock | 4.00K | 4.00K | 4.00K | 3.00K | 2.00K | 2.00K |
| Additional Paid-In Capital | 1.18B | 1.17B | 1.14B | 713.64M | 505.86M | 366.93M |
| Retained Earnings | -534.18M | -481.76M | -568.78M | -381.43M | -228.43M | -123.75M |
| Treasury Stock | -384.56M | -384.56M | ||||
| Total Common Equity | 262.32M | 303.13M | 571.55M | 332.21M | 277.42M | 243.17M |
| Shareholders' Equity | 262.32M | 303.13M | 571.55M | 332.21M | 277.42M | 243.17M |
| Total Liabilities & Equity | 287.60M | 338.02M | 615.89M | 370.02M | 306.78M | 255.25M |
| Total Debt | 15.72M | 16.88M | 18.86M | 14.44M | 13.27M | 1.09M |
| Net Cash (Debt) | 241.88M | 270.53M | 541.07M | 316.70M | 265.78M | 228.95M |
| Net Cash Per Share | 9.03 | 7.15 | 14.45 | 10.75 | 10.53 | 9.81 |
| Filing Date Shares Outstanding | 19.83M | 19.72M | 40.56M | 35.98M | 28.54M | 24.00M |
| Total Common Shares Outstanding | 19.83M | 19.54M | 40.55M | 31.84M | 27.54M | 23.97M |
| Working Capital | 254.73M | 295.02M | 561.44M | 322.92M | 269.22M | 239.59M |
| Book Value Per Share | 13.23 | 15.51 | 14.09 | 10.43 | 10.07 | 10.14 |
| Tangible Book Value | 262.32M | 303.13M | 571.55M | 332.21M | 277.42M | 243.17M |
| Tangible Book Value Per Share | 13.23 | 15.51 | 14.09 | 10.43 | 10.07 | 10.14 |
| Machinery | 8.73M | 7.19M | 5.85M | 2.97M | 1.92M | |
| Leasehold Improvements | 213.00K | 264.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -83.16M | 87.01M | -187.35M | -152.99M | -104.68M | -58.74M |
| Depreciation & Amortization | 1.60M | 1.51M | 1.23M | 815.00K | 674.00K | 378.00K |
| Loss (Gain) From Sale of Assets | 1.00K | -13.00K | 4.00K | 12.00K | 46.00K | |
| Stock-Based Compensation | 22.87M | 28.70M | 34.87M | 28.76M | 18.68M | 11.72M |
| Other Operating Activities | 2.52M | 2.41M | 1.82M | 1.55M | 941.00K | 520.00K |
| Change in Accounts Receivable | 15.82M | -825.00K | -2.60M | -143.00K | 18.00M | -18.00M |
| Change in Accounts Payable | -3.44M | -3.00M | -249.00K | 1.61M | -408.00K | 1.49M |
| Change in Unearned Revenue | -925.00K | |||||
| Change in Income Taxes | -8.57M | -2.25M | ||||
| Change in Other Net Operating Assets | 5.30M | -6.04M | -8.59M | -4.12M | -3.28M | 445.00K |
| Operating Cash Flow | -47.99M | 107.50M | -160.87M | -124.51M | -70.06M | -62.15M |
| Capital Expenditures | -494.00K | -1.55M | -1.93M | -2.46M | -1.24M | -1.02M |
| Investing Cash Flow | -494.00K | -1.55M | -1.93M | -2.46M | -1.24M | -1.02M |
| Issuance of Common Stock | 297.00K | 288.00K | 392.27M | 179.05M | 120.40M | 28.55M |
| Repurchase of Common Stock | -384.56M | -378.90M | ||||
| Other Financing Activities | 139.00K | 139.00K | -454.00K | -94.00K | -87.00K | |
| Financing Cash Flow | -384.12M | -378.47M | 391.82M | 178.96M | 120.31M | 28.55M |
| Net Cash Flow | -432.61M | -272.52M | 229.02M | 51.98M | 49.01M | -34.62M |
| Free Cash Flow | -48.49M | 105.95M | -162.80M | -126.97M | -71.30M | -63.17M |
| Free Cash Flow Margin | -322.94% | 43.41% | -4,585.91% | -84,087.42% | -314.29% | |
| Free Cash Flow Per Share | -1.81 | 2.80 | -4.35 | -4.31 | -2.83 | -2.71 |
| Levered Free Cash Flow | -27.17M | 66.24M | -108.31M | -81.25M | -33.84M | -39.48M |
| Unlevered Free Cash Flow | -27.17M | 66.24M | -108.31M | -81.25M | -33.84M | -39.48M |
| Cash Income Tax Paid | 5.64M | 7.14M | ||||
| Change in Working Capital | 8.18M | -12.11M | -11.44M | -2.65M | 14.31M | -16.07M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 221.47M | 620.29M | 641.23M | 1.19B | 1.32B | 1.37B |
| Enterprise Value | -20.41M | -55.75M | 129.83M | 917.61M | 1.08B | 1.15B |
| Last Close Price | 11.04 | 20.36 | 15.83 | 39.76 | 48.02 | 58.51 |
| PE Ratio | 7.13 | |||||
| PS Ratio | 14.58 | 2.54 | 180.63 | 7,888.64 | 68.11 | |
| PB Ratio | 0.83 | 2.05 | 1.12 | 3.59 | 4.77 | 5.63 |
| P/TBV Ratio | 0.83 | 2.05 | 1.12 | 3.59 | 4.77 | 5.63 |
| P/FCF Ratio | 5.85 | |||||
| P/OCF Ratio | 5.77 | |||||
| EV/Sales Ratio | 36.57 | 6,076.87 | 57.16 | |||
| Debt / Equity Ratio | 0.06 | 0.06 | 0.03 | 0.04 | 0.05 | 0.00 |
| Debt / EBITDA Ratio | 0.21 | |||||
| Debt / FCF Ratio | 0.16 | |||||
| Net Debt / Equity Ratio | -0.92 | -0.89 | -0.95 | -0.95 | -0.96 | -0.94 |
| Net Debt / EBITDA Ratio | 2.50 | -3.75 | 2.58 | 1.87 | 2.33 | 4.09 |
| Net Debt / FCF Ratio | 4.99 | -2.55 | 3.32 | 2.49 | 3.73 | 3.62 |
| Asset Turnover | 0.03 | 0.51 | 0.01 | 0.00 | 0.08 | |
| Quick Ratio | 21.47 | 15.10 | 20.56 | 13.63 | 16.91 | 20.96 |
| Current Ratio | 21.96 | 15.45 | 21.45 | 14.25 | 17.27 | 21.23 |
| Return on Equity (ROE) | -17.16% | 19.90% | -41.46% | -50.19% | -40.22% | -23.27% |
| Return on Assets (ROA) | -11.78% | 9.25% | -26.73% | -31.39% | -25.53% | -13.43% |
| Return on Invested Capital (ROIC) | -481.72% | 211.85% | -691.64% | -396.30% | ||
| Return on Capital Employed (ROCE) | -35.70% | 22.20% | -35.80% | -49.20% | -39.60% | -23.20% |
| Earnings Yield | -27.79% | 14.03% | -29.22% | -12.84% | -7.91% | -4.29% |
| FCF Yield | -22.15% | 17.08% | -25.39% | -10.66% | -5.39% | -4.61% |
| Buyback Yield / Dilution | 33.15% | -1.13% | -27.13% | -16.66% | -8.17% | -50.48% |